http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101136251-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N41-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-00
filingDate 2008-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101136251-B1
titleOfInvention helminthic
abstract The present invention provides a compound of formula (I) or a tautomer or prodrug thereof, or a pharmaceutically acceptable salt of said compound, tautomer or prodrug; Compositions containing such compounds; And the use of such compounds as an antiparasitic agent.n n n <Formula I>n n n n n n n n Wherein,n n n R 1 , R 2 , R 3 , R 4 and R 5 are each independently selected from H, halo, CN, CF 3 and CONH 2 .
priorityDate 2007-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060088122-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466576805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467441896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455661788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466578017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467441895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466577254

Total number of triples: 25.